23 November 2017
News and Views
Links and Services
A study in the latest issue of Gut investigates the usefulness of co-treatment with immunomodulatorstreated with scheduled infliximab maintenance therapy.
Concomitant use of immunosuppressants with scheduled infliximab maintenance therapy for Crohn's d
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors